REVENUE RECOGNITION AND COLLABORATIVE ARRANGEMENTS (Tables)

12 Months Ended

Dec. 31, 2018

REVENUE RECOGNITION AND COLLABORATIVE ARRANGEMENTS

Schedule of revenue from collaborative arrangements

	Year Ended December 31,
(In thousands)	2018		2017		2016
Royalties from a related party—RELVAR/BREO	$	220,162	$	198,726	$	128,638
Royalties from a related party—ANORO		41,286		29,036		17,869
Royalties from a related party—TRELEGY		13,379		179		—
Total royalties from a related party		274,827		227,941		146,507
Less: amortization of capitalized fees paid to a related party		(13,823)		(13,823)		(13,823)
Royalty revenue		261,004		214,118		132,684
Strategic alliance - MABA program license		—		3,099		885
Total net revenue from GSK	$	261,004	$	217,217	$	133,569